In a potentially pivotal trial, PTC Therapeutics' experimental therapy for Huntington's disease (HD) met its primary endpoint, but questions about the data have raised doubts about the company's ...

Novartis has made a dramatic return to the Huntington's disease therapy stage by licensing a candidate from PTC Therapeutics for a whopping $1 billion upfront. The deal – which has a potential total ...

PTC Industries Limited is an India-based company, which is engaged in manufacturing of precision metal components for critical applications. It is primarily engaged in the manufacturing of metal ...

Chart does not reflect overnight price.

Discover historical prices for PTC stock on Yahoo Finance. View daily, weekly or monthly format back to when PTC Inc. stock was issued.